vs
Generation Bio Co.（GBIO）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是Generation Bio Co.的1.2倍（$1.9M vs $1.6M），Generation Bio Co.净利率更高（-346.3% vs -974.7%，领先628.4%），Rigetti Computing, Inc.同比增速更快（-17.9% vs -78.9%），过去两年Rigetti Computing, Inc.的营收复合增速更高（-21.8% vs -25.6%）
Generation Bio Co.是一家临床阶段生物技术企业，专注开发针对罕见及常见遗传疾病的创新非病毒基因疗法，核心管线覆盖肝脏、视网膜疾病适应症，主要在美国市场运营，致力于为存在未满足医疗需求的患者提供潜在一次性治愈方案。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
GBIO vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.2倍
$1.6M
营收增速更快
RGTI
高出61.0%
-78.9%
净利率更高
GBIO
高出628.4%
-974.7%
两年增速更快
RGTI
近两年复合增速
-25.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $1.9M |
| 净利润 | $-5.5M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -420.8% | -1209.7% |
| 净利率 | -346.3% | -974.7% |
| 营收同比 | -78.9% | -17.9% |
| 净利润同比 | 64.0% | 88.1% |
| 每股收益（稀释后） | $-0.82 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GBIORGTI
| Q4 25 | — | $1.9M | ||
| Q3 25 | $1.6M | $1.9M | ||
| Q2 25 | $765.0K | $1.8M | ||
| Q1 25 | $8.7M | $1.5M | ||
| Q4 24 | $4.2M | $2.3M | ||
| Q3 24 | $7.6M | $2.4M | ||
| Q2 24 | $4.1M | $3.1M | ||
| Q1 24 | $4.1M | $3.1M |
净利润GBIORGTI
| Q4 25 | — | $-18.2M | ||
| Q3 25 | $-5.5M | $-201.0M | ||
| Q2 25 | $-20.9M | $-39.7M | ||
| Q1 25 | $-14.8M | $42.6M | ||
| Q4 24 | $-21.4M | $-153.0M | ||
| Q3 24 | $-15.3M | $-14.8M | ||
| Q2 24 | $-20.4M | $-12.4M | ||
| Q1 24 | $-74.5M | $-20.8M |
毛利率GBIORGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率GBIORGTI
| Q4 25 | — | -1209.7% | ||
| Q3 25 | -420.8% | -1055.4% | ||
| Q2 25 | -2995.6% | -1103.9% | ||
| Q1 25 | -190.4% | -1469.6% | ||
| Q4 24 | -562.6% | -813.3% | ||
| Q3 24 | -236.7% | -729.4% | ||
| Q2 24 | -569.8% | -521.2% | ||
| Q1 24 | -1912.6% | -543.4% |
净利率GBIORGTI
| Q4 25 | — | -974.7% | ||
| Q3 25 | -346.3% | -10321.9% | ||
| Q2 25 | -2735.0% | -2201.8% | ||
| Q1 25 | -169.7% | 2895.3% | ||
| Q4 24 | -510.6% | -6726.5% | ||
| Q3 24 | -202.7% | -623.8% | ||
| Q2 24 | -499.4% | -402.5% | ||
| Q1 24 | -1836.4% | -680.6% |
每股收益（稀释后）GBIORGTI
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.82 | $-0.62 | ||
| Q2 25 | $-3.12 | $-0.13 | ||
| Q1 25 | $-0.22 | $0.13 | ||
| Q4 24 | $4.50 | $-0.80 | ||
| Q3 24 | $-2.29 | $-0.08 | ||
| Q2 24 | $-3.07 | $-0.07 | ||
| Q1 24 | $-1.12 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.6M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $50.6M | $546.2M |
| 总资产 | $121.9M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GBIORGTI
| Q4 25 | — | $44.9M | ||
| Q3 25 | $89.6M | $26.1M | ||
| Q2 25 | $141.4M | $57.2M | ||
| Q1 25 | $157.6M | $37.2M | ||
| Q4 24 | $185.2M | $67.7M | ||
| Q3 24 | $184.8M | $20.3M | ||
| Q2 24 | $216.9M | $20.7M | ||
| Q1 24 | $219.3M | $35.1M |
股东权益GBIORGTI
| Q4 25 | — | $546.2M | ||
| Q3 25 | $50.6M | $371.8M | ||
| Q2 25 | $54.1M | $553.3M | ||
| Q1 25 | $73.3M | $207.1M | ||
| Q4 24 | $86.2M | $126.6M | ||
| Q3 24 | $104.4M | $122.8M | ||
| Q2 24 | $115.4M | $122.2M | ||
| Q1 24 | $132.0M | $115.6M |
总资产GBIORGTI
| Q4 25 | — | $666.6M | ||
| Q3 25 | $121.9M | $630.3M | ||
| Q2 25 | $179.4M | $636.7M | ||
| Q1 25 | $201.3M | $269.1M | ||
| Q4 24 | $231.2M | $284.8M | ||
| Q3 24 | $248.8M | $157.3M | ||
| Q2 24 | $265.3M | $162.4M | ||
| Q1 24 | $285.9M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-52.7M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.5M |
| 自由现金流率自由现金流/营收 | — | -1042.5% |
| 资本支出强度资本支出/营收 | 0.0% | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-77.2M |
8季度趋势，按日历期对齐
经营现金流GBIORGTI
| Q4 25 | — | $-14.9M | ||
| Q3 25 | $-52.7M | $-13.8M | ||
| Q2 25 | $-16.8M | $-16.2M | ||
| Q1 25 | $-28.4M | $-13.7M | ||
| Q4 24 | $-15.8M | $-8.5M | ||
| Q3 24 | $-19.5M | $-15.4M | ||
| Q2 24 | $-21.5M | $-13.5M | ||
| Q1 24 | $-31.7M | $-13.1M |
自由现金流GBIORGTI
| Q4 25 | — | $-19.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | $-17.3M | $-21.8M | ||
| Q1 25 | $-28.6M | $-16.2M | ||
| Q4 24 | $-16.2M | $-9.8M | ||
| Q3 24 | $-19.6M | $-17.7M | ||
| Q2 24 | $-21.5M | $-15.6M | ||
| Q1 24 | $-33.6M | $-18.6M |
自由现金流率GBIORGTI
| Q4 25 | — | -1042.5% | ||
| Q3 25 | — | -1012.4% | ||
| Q2 25 | -2259.7% | -1212.4% | ||
| Q1 25 | -327.9% | -1100.4% | ||
| Q4 24 | -385.9% | -432.1% | ||
| Q3 24 | -260.0% | -744.5% | ||
| Q2 24 | -526.7% | -504.3% | ||
| Q1 24 | -828.2% | -610.5% |
资本支出强度GBIORGTI
| Q4 25 | — | 244.8% | ||
| Q3 25 | 0.0% | 302.5% | ||
| Q2 25 | 60.0% | 314.7% | ||
| Q1 25 | 2.8% | 173.0% | ||
| Q4 24 | 9.0% | 56.4% | ||
| Q3 24 | 1.2% | 95.8% | ||
| Q2 24 | 0.3% | 66.3% | ||
| Q1 24 | 47.3% | 180.0% |
现金转化率GBIORGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GBIO
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
